Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 502281949

SARS-CoV-2 Nucleocapsid protein Monoclonal Antibody (1G4), Biotin, Bioss
SDP

Catalog No. 502281949
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-228-1949 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 50-228-1949 Supplier Bioss Supplier No. BSM41267MBIOTIN
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

SARS-CoV-2 Nucleocapsid protein Monoclonal antibody specifically detects SARS-CoV-2 Nucleocapsid protein in Virus samples. It is validated for Western Blot

Specifications

Antigen SARS-CoV-2 Nucleocapsid protein
Applications Western Blot
Classification Monoclonal
Clone 1G4
Concentration 1 mg/mL
Conjugate Biotin
Formulation TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Gene N
Gene Accession No. P59595
Gene Alias COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid
Host Species Mouse
Immunogen Recombinant SARS-CoV-2 N protein (His-tag)
Purification Method Protein G
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 1489678
Target Species Virus
Content And Storage -20° C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.